Pluristyx is dedicated to assisting our clients in the development of revolutionary cellular therapeutics. We offer a portfolio of induced Pluripotent Stem Cell (iPSC) products that are available in both research and clinical grade, as well as services that are widely applicable to numerous allogenic cellular therapies. Pluristyx provides end-to-end support for early product development. We are committed to lowering the barrier to entry, providing a swift translation to clinic, and ensure the best path to commercialization for the next generation of iPSC-derived treatments.